Glaxosmithkline Pharmaceuticals consolidated net profit declines 89.62% in the March 2021 quarter

Sales rise 4.89% to Rs 813.75 crore

Net profit of Glaxosmithkline Pharmaceuticals declined 89.62% to Rs 14.33 crore in the quarter ended March 2021 as against Rs 138.07 crore during the previous quarter ended March 2020. Sales rose 4.89% to Rs 813.75 crore in the quarter ended March 2021 as against Rs 775.80 crore during the previous quarter ended March 2020.

For the full year,net profit rose 284.28% to Rs 358.15 crore in the year ended March 2021 as against Rs 93.20 crore during the previous year ended March 2020. Sales declined 0.79% to Rs 3198.86 crore in the year ended March 2021 as against Rs 3224.38 crore during the previous year ended March 2020.

 

ParticularsQuarter EndedYear EndedMar. 2021Mar. 2020% Var.Mar. 2021Mar. 2020% Var.Sales813.75775.80 5 3198.863224.38 -1 OPM %21.0022.37 -21.7420.38 - PBDT199.86187.87 6 802.38729.92 10 PBT182.01165.28 10 723.10647.24 12 NP14.33138.07 -90 358.1593.20 284

Powered by Capital Market - Live News